2004
DOI: 10.1093/hmg/ddh330
|View full text |Cite
|
Sign up to set email alerts
|

The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway

Abstract: Paroxysmal non-kinesigenic dyskinesia (PNKD) is characterized by spontaneous hyperkinetic attacks that are precipitated by alcohol, coffee, stress and fatigue. We report mutations in the myofibrillogenesis regulator 1 (MR-1) gene causing PNKD in 50 individuals from eight families. The mutations cause changes (Ala to Val) in the N-terminal region of two MR-1 isoforms. The MR-1L isoform is specifically expressed in brain and is localized to the cell membrane while the MR-1S isoform is ubiquitously expressed and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
118
1
12

Year Published

2005
2005
2017
2017

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 174 publications
(135 citation statements)
references
References 42 publications
4
118
1
12
Order By: Relevance
“…A Rabbit antibody (C2235) was raised against the carboxyl-terminus peptide of PNKD, and against the N-terminal peptide (2226) (9). RIM antibody (BD Biosciences) recognizes both RIM1 and RIM2.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…A Rabbit antibody (C2235) was raised against the carboxyl-terminus peptide of PNKD, and against the N-terminal peptide (2226) (9). RIM antibody (BD Biosciences) recognizes both RIM1 and RIM2.…”
Section: Methodsmentioning
confidence: 99%
“…PNKD is interesting in that the gene encodes a novel protein with homology to human glyoxalase II, an enzyme in a stress-response pathway. Although the normal role of PNKD is unknown, we previously identified the causative gene of PNKD (9) and a mouse model of the human mutations recapitulates the phenotype and shows dopamine signaling dysregulation (10).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Although mutations in the MR1 gene located on chromosome 2q35 encoding a protein with unknown function have been described for PNKD (6,7), the underlying pathophysiology of PDs remains largely elusive. Analogous to idiopathic epilepsies and other episodic neurological disorders (8,9), disruption of ionic homeostasis by dysfunction of channels or transporters could play a pathophysiological role in PDs.…”
Section: Introductionmentioning
confidence: 99%
“…nausea, headache, diaphoresis, clumsiness, stiffening of the body, and dysarthric speech. The duration of the attacks is brief, lasting seconds to minutes, although prolonged attacks of 5-12 h have been described (Lee et al, 2004). Some individuals experience severe ataxia more than 15 times per day, whereas others experience attacks less than once a month (Van Dyke et al, 1975).…”
Section: Paroxysmal Movement Disordersmentioning
confidence: 99%